Cite
HARVARD Citation
Andreone, P. et al. (2015). Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial. Digestive and liver disease. 47 (12), pp. 1059-1066. [Online].